Gleason Group’s CVS Health CVS Stock Holding History

Gleason Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.41K	Buy	+62	New	+$5.53K	﹤0.01%	283
2024 Q3	–	Sell	-147	Closed	-$8.68K	–	210
2024 Q2	$8.68K	Buy	+147	New	+$9.2K	﹤0.01%	199
2023 Q2	–	Sell	-57	Closed	-$4.21K	–	233
2023 Q1	$4.21K	Buy	57 +1	+2%	+$84	﹤0.01%	201
2022 Q4	$5.25K	Hold	56	–	–	﹤0.01%	189
2022 Q3	$5K	Buy	56 +1	+2%	+$99	﹤0.01%	198
2022 Q2	$5K	Hold	55	–	–	﹤0.01%	195
2022 Q1	$6K	Hold	55	–	–	﹤0.01%	180
2021 Q4	$6K	Buy	55 +1	+2%	+$92	﹤0.01%	172
2021 Q3	$5K	Hold	54	–	–	﹤0.01%	180
2021 Q2	$5K	Hold	54	–	–	﹤0.01%	178
2021 Q1	$4K	Buy	54 +1	+2%	+$73	﹤0.01%	175
2020 Q4	$4K	Hold	53	–	–	﹤0.01%	170
2020 Q3	$3K	Buy	53 +1	+2%	+$62	﹤0.01%	164
2020 Q2	$3K	Hold	52	–	–	﹤0.01%	167
2020 Q1	$3K	Buy	+52	New	+$3.47K	﹤0.01%	164

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Gleason Group's CVS Position: Q2 2026 in Review

Gleason Group opened a new position in CVS Health (CVS) in Q2 2026: 62 shares worth $6.41K. The stake represents ﹤0.01% of the portfolio and ranks #283 among its holdings. This is a return to the name: Gleason Group previously reported a position in CVS as recently as Q2 2024.

Gleason Group first reported a position in CVS in Q1 2020 and has held it in 15 quarters since. The position peaked at $8.68K in Q2 2024. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Gleason Group held 62 shares of CVS Health worth $6.41K as of Q2 2026.
CVS Health was a new Gleason Group position in Q2 2026.
CVS Health made up ﹤0.01% of Gleason Group's portfolio in Q2 2026, its #283 holding.
Gleason Group first reported a position in CVS Health in Q1 2020 and has held it in 15 quarters since.
Gleason Group's CVS Health position peaked at $8.68K in Q2 2024.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Gleason Group's 13F filing for Q2 2026, filed 13 Jul 2026.